MapLight Therapeutics, Inc. (MPLT)
9.82
+0.19
(+1.97%)
USD |
NASDAQ |
Oct 02, 16:00
9.82
0.00 (0.00%)
Pre-Market: 08:00
MapLight Therapeutics Net Income (Quarterly) : -60.19M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -60.19M |
| March 31, 2026 | -60.67M |
| December 31, 2025 | -79.55M |
| September 30, 2025 | -29.42M |
| June 30, 2025 | -29.85M |
| Date | Value |
|---|---|
| March 31, 2025 | -22.34M |
| June 30, 2024 | -18.40M |
| March 31, 2024 | -18.94M |
| March 31, 2023 | -11.98M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -4.89M |
| Cullinan Therapeutics, Inc. | -53.70M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 60.19M |
| EPS Diluted (Quarterly) | -1.325 |
| Enterprise Value | 143.45M |
| Earnings Yield | -52.16% |
| Normalized Earnings Yield | -52.16 |